Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved protection by recombinant BCG.

Ali Nasser Eddine1, Stefan H E Kaufmann

  • 1Department of Immunology, Max-Planck Institute for Infection Biology, Schumannstr. 21/22, 10117 Berlin, Germany.

Microbes and Infection
|May 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GATA-3 localization shapes lymphocyte function.

Cell reports·2026
Same author

Modeling immune responses of cattle to <i>Mycobacterium bovis</i> using magnetic bioprinted granulomas.

mSphere·2025
Same author

Sex Differences in Vaccine-Induced Immunity and Protection Against Mycobacterium tuberculosis.

The Journal of infectious diseases·2025
Same author

The Paediatric BCG Vaccine Century: From Historical Success to Future Innovations.

Acta paediatrica (Oslo, Norway : 1992)·2025
Same author

The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture Conversion.

Pathogens & immunity·2025
Same author

Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth.

eLife·2024
Same journal

The extent of monocytic myeloid suppressor cells induction determines the host immune response during Mycobacterium avium infection.

Microbes and infection·2025
Same journal

Culture-attenuated pathogenic Leptospira lose the ability to survive complement lytic activity due to decreased C4BP uptake.

Microbes and infection·2025
Same journal

Exploring the link between genetically predicted plasma cathepsins and COVID-19: A mendelian randomization study of susceptibility and severity.

Microbes and infection·2025
Same journal

Laboratory parameters and serum tube agglutination test as markers for brucellosis treatment response.

Microbes and infection·2025
Same journal

Corrigendum to "Lactococcus lactis and Bifidobacterium longum attenuate Clostridioides difficile- or Clostridium symbiosum-induced colitis and depression/anxiety-like behavior in male mice" [Microb Infect 27(7) (2025) 105560].

Microbes and infection·2025
Same journal

Disrupted Microbiome-Metabolome networks underlie gut barrier and immune imbalance in severe fever with thrombocytopenia syndrome.

Microbes and infection·2025
See all related articles

Mycobacterium bovis bacille Calmette Guérin (BCG) is a widely used live vaccine. Genome manipulation allows for creating recombinant BCG (rBCG) strains, offering a safer and more effective tuberculosis vaccine.

Area of Science:

  • Vaccinology
  • Microbiology
  • Immunology

Background:

  • Mycobacterium bovis bacille Calmette Guérin (BCG) is a cornerstone live vaccine globally.
  • Current BCG vaccines face challenges with safety and efficacy against tuberculosis.

Purpose of the Study:

  • To explore the potential of recombinant BCG (rBCG) as an improved vaccine against tuberculosis.
  • To leverage advancements in genome manipulation for vaccine development.

Main Methods:

  • Utilizing modern genome manipulation techniques.
  • Constructing novel recombinant BCG (rBCG) strains.

Main Results:

  • rBCG strains demonstrate potential for enhanced immunogenicity.
  • rBCG exhibits an improved safety profile compared to conventional BCG.

Related Experiment Videos

Conclusions:

  • Recombinant BCG (rBCG) represents a promising next-generation vaccine candidate for tuberculosis.
  • Genome engineering offers a viable strategy to enhance vaccine safety and efficacy.